ArticleScientific reports2025
Isolation and partial characterization of antimicrobial peptide-enriched fractions from Parabacteroides distasonis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parabacteroides distasonis is a part of the indigenous human microbiota and plays a significant role in disease etiopathogenesis. This study aimed to evaluate the efficacy of peptides isolated from P. distasonis strains. We focused on the expression, purification, characterization, antimicrobial efficacy through antagonism assays, and in silico studies of antimicrobial peptides produced by 78 P. distasonis strains. Methodology: Seventy-eight P. distasonis strains isolated from broiler (Gallus gallus domesticus) feces were evaluated. Antagonistic activity was assessed using the double-layer diffusion method. The influence of pH, temperature, proteolytic enzymes, and organic solvents on the intracellular peptide fraction (C-50) was analyzed. MIC was determined according to CLSI guidelines with adaptations. The peptide was purified, and its N-terminal amino acid sequence was determined using MALDI-TOF. Sequence identity was confirmed through BLAST-P analysis. Membrane docking was also conducted. Results: Fifty percent of the tested isolates produced antagonistic substances against at least one indicator strain. The C-50 fraction displayed stable antagonistic activity across a wide pH range (5.0-10.0) but was inactivated above 70 °C. MIC and MBC values for P. distasonis ATCC 1295 were 1.81 mg/mL (6.25 AU/mL) and 23.24 mg/mL (160 AU/mL), respectively. Ion-exchange chromatography revealed two peaks of activity. The major active peptide showed 100% identity to segments of histone-like H1 from Bacteroides fragilis. Exploratory molecular docking suggested plausible interactions. These computational findings are preliminary and require experimental validation. This study reports the discovery and partial biochemical characterization of antimicrobial peptides from P. distasonis. The peptides demonstrated extract-level activity and sequence similarity to histone-like proteins. Detailed mechanism of action and safety validation require further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.